title: Bortezomib in systemic AL amyloidosis: a single center experience.
authors.affiliation: University of Medicine and Pharmacy Carol Davila, Bucharest, Romania.
authors.forename: D
authors.initials: D
authors.lastname: Coriu
authors.forename: S
authors.initials: S
authors.lastname: Badelita
authors.forename: R
authors.initials: R
authors.lastname: Talmaci
authors.forename: C
authors.initials: C
authors.lastname: Dobrea
authors.forename: M
authors.initials: M
authors.lastname: Dogaru
authors.forename: D
authors.initials: D
authors.lastname: Ostroveanu
authors.forename: M
authors.initials: M
authors.lastname: Crisan
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000188:drug therapy*; D001897:Boronic Acids / Q000627:therapeutic use*; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007147:Immunoglobulin Light Chains; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000627:therapeutic use*
chemical_list: D001897:Boronic Acids; D007147:Immunoglobulin Light Chains; D011719:Pyrazines; D000069286:Bortezomib